510(k) Report

510(k) · Cleared

Cleared

Elpha 2000 Conti

K964738510(k) TraditionalCleared Aug 14, 1997274-day reviewClass II21 CFR 876.5320

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Dan Med, Inc. · KPI Stimulator, Electrical, Non-Implantable, For Incontinence

Cleared on Aug 14, 1997 after a 274-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 40 later devices descend from it.

Decided
Aug 14, 1997
Review
274 days
Class
Class II
Product code
KPI
Recalls
None
Predicates
0

40 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2002: 1 descendant cleared2001: 1 descendant cleared2005: 1 descendant cleared2014: 3 descendants cleared2012: 1 descendant cleared2006: 1 descendant cleared2021: 2 descendants cleared2009: 1 descendant cleared2020: 3 descendants cleared2015: 4 descendants cleared2018: 2 descendants cleared2019: 2 descendants cleared2024: 1 descendant cleared2025: 5 descendants cleared2023: 4 descendants cleared2026: 5 descendants cleared2022: 3 descendants cleared1995200020052010201520202025
  1. This deviceK964738 Elpha 2000 ContiDan Med, Inc. · 1997
  2. Descendant · cites it directly · 38 of its ownK013612 Incare Pelvic Floor Therapy SystemHollister, Inc. · 2002
  3. Descendant · 2 generations on · 37 of its ownK050483 Evadri Bladder Control SystemsHollister, Inc. · 2005
  4. Descendant · 3 generations on · 36 of its ownK053434 Myotrac Infiniti Electrical StimulatorThought Technology, Ltd. · 2006
  5. Descendant · 4 generations on · 34 of its ownK080950 Stiwell MED4Otto Bock, Austria GmbH · 2009
  6. Descendant · 3 generations on · 21 of its ownK110179 IncontrolIncontrol Medical, LLC · 2012

Showing 5 of 40 descendants. See all descendants

Descendants cleared per year

2001: 12002: 12005: 12006: 12009: 12012: 12014: 32015: 42018: 22019: 22020: 32021: 22022: 32023: 42024: 12025: 52026: 5
2001high 5 (2025) · low 0 (2003)2026

Most influential descendants

Showing 5 of 40 · See all
  • K013612Incare Pelvic Floor Therapy SystemHollister, Inc. · 2002 · cites it directly38descendants
  • K050483Evadri Bladder Control SystemsHollister, Inc. · 2005 · 2 generations on37descendants
  • K053434Myotrac Infiniti Electrical StimulatorThought Technology, Ltd. · 2006 · 3 generations on36descendants
  • K080950Stiwell MED4Otto Bock, Austria GmbH · 2009 · 4 generations on34descendants
  • K110179IncontrolIncontrol Medical, LLC · 2012 · 3 generations on21descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K964738Elpha 2000 ContiDan Med, Inc.1997—
+1K013612Incare Pelvic Floor Therapy SystemHollister, Inc.2002—
+2K050483Evadri Bladder Control SystemsHollister, Inc.2005—
+3K053434Myotrac Infiniti Electrical StimulatorThought Technology, Ltd.2006—
+4K080950Stiwell MED4Otto Bock, Austria GmbH2009—
+3K110179IncontrolIncontrol Medical, LLC2012—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200110
200210
200510
200610
200910
201210
201430
201540
201820
201920
202030
202120
202230
202340
202410
202550
202650
FIG. 1 — Lineage of K964738, 1997–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KPI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KPI device

  1. #1 K262353 BTL-299-Fscore 14.8 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (40)

See all 40

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K013612Incare Pelvic Floor Therapy SystemHollister, Inc.200238
K013141Microgyn Plus Stimulation DeviceHollister, Inc.20010

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K013612 (Hollister, Inc., 2002) has gone furthest, with 38 descendants of its own.

How does its category compare?

All KPI devices

KPI Stimulator, Electrical, Non-Implantable, For Incontinence: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · KPI

7so far in 2026, the most since 2007

2007: 12008: 12009: 22011: 12012: 22013: 12014: 32015: 62016: 32017: 12018: 32019: 22020: 12021: 32022: 32023: 32024: 42025: 42026 (partial year): 7
2007high 7 (2026) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KPI

263in 2025

2014: 57 days median2015: 260 days median2016: 89 days median2018: 304 days median2021: 217 days median2022: 181 days median2023: 197 days median2024: 172 days median2025: 263 days median2026 (partial year): 248 days median
2007high 304 (2018) · low 57 (2014)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KPI

No recall names KPI since 2007.

Adverse event reports per year · KPI

2in 2024

2013: 12015: 22017: 42019: 22020: 32021: 12022: 22023: 62024: 2
2007high 6 (2023) · low 0 (2007)2025

MAUDE reports naming product code KPI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20081—00
20092—00
20100—00
20111—00
20122—00
20131—01
201435700
2015626002
201638900
20171—04
2018330400
20192—02
20201—03
2021321701
2022318102
2023319706
2024417202
2025426300
202672480—

What is it indicated for?

Electrical stimulation of the pelvic floor muscles with the use of vaginal probe. The effect is strengthening the pelvic floor muscles and an activation of the central nervous system.

Electrical stimulation of the pelvic floor muscles can reduce urinary incontinence among stress and urge incontinent adult females.

Indications for use read by OCR from a scanned FDA 510(k) statement, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K964738: Elpha 2000 Conti.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K964738

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026